tm logo
DUETRE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 10 May 2021

Last Applicant/ Owned by

1090 Horsham Road

North Wales

PA

19454

Serial Number

87676275 filed on 08th Nov 2017

Registration Number

N/A

Correspondent Address

Teva Pharmaceuticals USA, Inc.

1090 Horsham Road

North Wales PA 19454

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DUETRE

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the preveRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Mark Details


Serial Number

No 87676275

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th May 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
10th May 2021ABANDONMENT - NO USE STATEMENT FILED
03rd Oct 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01st Oct 2020EXTENSION 3 GRANTED
01st Oct 2020TEAS EXTENSION RECEIVED
01st Oct 2020EXTENSION 3 FILED
08th Apr 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06th Apr 2020EXTENSION 2 GRANTED
06th Apr 2020EXTENSION 2 FILED
06th Apr 2020TEAS EXTENSION RECEIVED